Eating Disorder Therapy market accounted for US$457.5Mn in 2020 and is estimated to be 2030 US$ 763.8Mn 2029 and is anticipated to register a CAGR of 5.3%
Eating Disorder
Therapy Market accounted for
US$457.5Mn in 2020 and is estimated to be 2030 US$ 763.8Mn 2029 and
is anticipated to register a CAGR of 5.3% . The growth of the global eating
disorder market is increasing rapidly due to changing habits and lifestyle of
today’s generation. Further, mental illness is also the major cause of eating
disorders due to stress, anxiety and mood swings. According to World Health
Organization (WHO), 9% of the population worldwide is affected by the eating
disorders. Women with physical disability are more likely to be prone to eating
disorders. The most common type of eating disorder is bulimia nervosa, which is
commonly found among military members. Approved drugs in the eating
disorder market includes Edgemont pharmaceuticals Floxetine Tablets and shire’s
Vyvanse theses drugs are administered via oral route. Only three drugs are in
active clinical development for eating disorder, with two drugs in phase 2 and
one in phase 3. Therapies in eating disorder basically targets dopamine
reuptake, opioid reuptake and ghrelin receptor.
The
report "Global Eating Disorder Therapy Market, is segmented into By
Type (Anorexia Nervosa, Binge Eating Disorder, bulimia Nervosa, Pica,
Avoidant/Restrictive Food Intake Disorder, Rumination Disorder, Night Eating
Syndrome, Purging Disorder, Others), By Patients(Inpatients, Outpatients), By
Treatment (Medications, Therapy, Others ), By Route Of Administration (Oral,
Parenteral, Others), By End – Users(Hospitals, Clinics, Others), By Region
(North America, Europe, Asia Pacific, Latin America And Middle East &
Africa) – Market Trends, Analysis, And Forecast Till 2029.
Key Highlights:
·
A new
initiative at UNC-Chapel Hill is kicking off a genetic study of eating
disorders that it says will be the largest of its kind.
·
According to
Essex Partnership University, young people living with new eating disorder will
receive specialist treatment more quickly by the new launch created by Essex.
They invented new launch which is named as FREED.
·
Equip, a
company that delivers virtual eating disorder treatment, on Feb. 10 closed
a US$13 million series A funding round led by Optum's venture capital arm,
bringing its total amount of funds raised to US $17 million.
Analyst View:
Eating disorder is the most common type of disorder found
worldwide. It is affected by the lifestyle and the environment. There are
different types of eating disorders found which totally depend on the mental
and physical health of a person. Today’s youth generation is facing several
personal and professional health issues, which led to misdiagnosis of the
condition. People think that it a normal issue but in reality it can affect whole
life of a person. Therefore, proper medication should be provided on time to
avoid health related issues.
Before purchasing this report, request a sample or make an inquiry
by clicking the following link:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4640
Key Market Insights from the report:
The Global Eating Disorder Therapy market accounted for
US$457.5Mn in 2020 and is estimated to be US$ 763.8Mn million by 2030 and is
anticipated to register a CAGR of 5.3%The Global Eating Disorder Therapy market
is segmented based on the type, patient, treatment, route of administration,
end users, and by region.
·
By type, the
Global Eating Disorder Therapy market is segmented into Anorexia Nervosa, Binge
Eating Disorder, bulimia Nervosa, Pica, Avoidant/Restrictive Food Intake
Disorder, Rumination Disorder, Night Eating Syndrome, Purging Disorder, Others
·
By patient,
the market is segmented in Inpatients and outpatients.
·
By Treatment,
the Global Eating Disorder Therapy market is segmented into Medications,
Therapy, Others
·
By end-user,
the target market is segmented into Hospitals, Clinics, Others.
·
By route of
administration, the target market is segmented into Oral, Parenteral, Others.
·
By region, the
Global Eating Disorder Therapy market is segmented into North America, Europe,
Asia Pacific, Latin America, and Middle East & Africa. North America is the
worldwide leader in the sepsis diagnostics market in terms of revenue, due to
the developed healthcare system and health awareness among people.
Competitive Landscape:
The key players operating in the Global Eating Disorder
Therapy market include Chronos Therapeutics, Shire US Inc., Eli Lilly and
Company, Sunovion Pharmaceuticals Inc., Promises Behavioral Health, Pyramid
Healthcare (Tapestry Eating Disorder Services), Timberline Knolls,
Rosewood Centers for Eating Disorders, Walden Behavioral Care.
The market provides detailed information regarding the
industrial base, productivity, strengths, manufacturers, and recent trends
which will help companies enlarge the businesses and promote financial growth.
Furthermore, the report exhibits dynamic factors including segments, sub-segments,
regional marketplaces, competition, dominant key players, and market forecasts.
In addition, the market includes recent collaborations, mergers, acquisitions,
and partnerships along with regulatory frameworks across different regions
impacting the market trajectory. Recent technological advances and innovations
influencing the global market are included in the report.
About Prophecy Market Insights
Prophecy Market Insights is specialized market research,
analytics, marketing/business strategy, and solutions that offers strategic and
tactical support to clients for making well-informed business decisions and to
identify and achieve high-value opportunities in the target business area. We
also help our clients to address business challenges and provide the best
possible solutions to overcome them and transform their business.
To know more
Contact Us:
Sales
Prophecy Market Insights
Email- sales@prophecymarketinsights.com
Website- www.prophecymarketinsights.com
Comments
Post a Comment